{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/195-EP2398517(active).pdf"}, "page_content": "\u2022 N.D. RAWLINGS ET AL.: \"MEROPS: the peptide database\", NUCLEIC ACIDS RESEARCH, vol. 34, 1 January 2006 (2006-01-01), pages D270-D272, DOI: 10.1093/nar/gkj089\n\n\u2022 D.L. Nelson, M.M. Cox: \"Lehninger Principles of Biochemistry, 4th Ed.\", pages 99-100,\n\nNote: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations. Notice of opposition shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).\n\nPrinted by Jouve, 75001 PARIS (FR)\n\n1\n\nEP 2 398 517 B1\n\n2\n\nDescription\n\nBACKGROUND OF THE INVENTION\n\nField of the Invention\n\n[0001] The present invention relates to controllable an- timicrobial and biocompatible titanium alloys for reducing post-operative implant-related bacterial infections. The present invention further relates to surface techniques and their mechanisms for modifying material surfaces so as to enhance the surface antimicrobial properties and achieve controllable release of antimicrobial peptides.\n\nDescription of the Related Art", "type": "Document"}}